A Phase 1b, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Safety, Engraftment, and Initial Signs of Clinical Activity of MB310 in Patients with Active, Mild to Moderate Ulcerative Colitis (COMPOSER-1)

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507376-50-00

Acronym

MB310-01

Enrollment

Registered

2024-08-13

Start date

2024-09-27

Completion date

2026-01-08

Last updated

2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Austria, Bulgaria, Poland, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026